Rifampin description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Rifampin

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

RIFAMPIN DESCRIPTION



Rifampin



CLINICAL PHARMACOLOGY

Oral Administration


WARNINGS


Pediatrics

Oral Administration


Microbiology







INDICATIONS AND USAGE















Susceptibility Tests










CLINICAL PHARMACOLOGY
INDICATIONS AND USAGE

MicroorganismMIC (mcg/mL)Staphylococcus aureusATCC 292130.008 - 0.06Enterococcus faecalisATCC 292121- 4Escherichia coliATCC 259228 - 32Pseudomonas aeruginosaATCC 2785332 - 64Haemophilus influenzaeATCC 492470.25 - 1Diffusion Techniques: Quantitative methods that require measurement of zone diameters provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure3,4 that has been recommended for use with disks to test the susceptibility of microorganisms to rifampin uses the 5 mcg rifampin disk. Interpretation involves correlation of the diameter obtained in the disk test with the MIC for rifampin.
Reports from the laboratory providing results of the standard single-disk susceptibility test with a 5 mcg rifampin disk should be interpreted according to the following criteria for Neisseria meningitidis.

Zone Diameter (mm)Interpretation20(S) Susceptible17-19(I) Intermediate16(R) ResistantInterpretation should be as stated above for results using dilution techniques.
As with standard dilution techniques, diffusion methods require the use of laboratory control microorganisms. The use of these microorganisms does not imply clinical efficacy (seeINDICATIONS AND USAGE

MicroorganismZone Diameter (mm)S. aureusATCC 2592326 - 34E. coliATCC 259228 - 10H. influenzaeATCC 4924722 - 30

INDICATIONS & USAGE



Tuberculosis




Meningococcal Carriers
WARNINGS



RIFAMPIN CONTRAINDICATIONS

WARNINGS
PRECAUTIONSDrug Interactions


WARNINGS






PRECAUTIONS

General






INFORMATION FOR PATIENTS








LABORATORY TESTS




DRUG INTERACTIONS

CONTRAINDICATIONS

Enzyme Induction

CONTRAINDICATIONS










DRUG & OR LABORATORY TEST INTERACTIONS




CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY

Teratogenic Effects

Teratogenic Effects


NURSING MOTHERS



PEDIATRIC USE

CLINICAL PHARMACOLOGYPediatricsDOSAGE AND ADMINISTRATION.

GERIATRIC USE

WARNINGS

RIFAMPIN ADVERSE REACTIONS

Gastrointestinal




Hematologic





Central Nervous System




Ocular


Endocrine



Renal


Dermatologic



Hypersensitivity Reactions



Miscellaneous


OVERDOSAGE

Signs and Symptoms




Acute Toxicity



Treatment




DOSAGE & ADMINISTRATION

INDICATIONS AND USAGECLINICAL PHARMACOLOGY

Tuberculosis






Incompatibilities:


Meningococcal Carriers




Preparation of Extemporaneous Oral Suspension









HOW SUPPLIED











STORAGE AND HANDLING





REFERENCES






PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Rifampin

Rifampin

Rifampin

Rifampin CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-447(NDC:0185-0801)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
rifampin RIFAMPIN 150 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
STARCH, CORN
D&C YELLOW NO. 10
DOCUSATE SODIUM
FD&C BLUE NO. 1
FD&C BLUE NO. 2
FD&C RED NO. 40
GELATIN
MAGNESIUM STEARATE
cellulose, microcrystalline
SODIUM BENZOATE
SODIUM LAURYL SULFATE
FERROSOFERRIC OXIDE
talc
titanium dioxide
D&C RED NO. 28

Product Characteristics

Color Size Imprint Code Shape
orange 18 mm E801 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-447-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA064150 2011-08-03


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.